泌尿外科雷射市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

预计 2020 年泌尿外科雷射市场价值约为 9.4479 亿美元，在预测期内以 5.51% 的复合年增长率增长。

预计 COVID-19 大流行将对市场增长产生重大影响。 冠状病毒的公共卫生影响，加上几乎完全暂停和取消外科手术的后果，对外科服务和有手术条件的患者产生了前所未有的影响。。 在高负担地区，手术室和麻醉机已被呼吸辅助设备暂时取代。 此外，根据一项题为“因 COVID-19 大流行而取消择期手术”的研究，“因 COVID-19 大流行而取消择期手术。计划报告称，在 COVID 的高峰期中断期间，近 250 万例良性泌尿外科手术被取消-19大流行。 在未来几週内，包括泌尿科医生在内的医护人员可能面临越来越复杂的挑战。 因此，应采用分流策略以避免浪费医疗资源。 在处理 COVID-19 患者时，还应坚持适当的保护政策以防止传播。 由于上述因素，大流行可能对延期择期手术研究市场产生短期负面影响。

推动市场发展的主要因素之一是世界泌尿系统疾病的高患病率。 女性尿失禁的患病率高于男性。 根据全球尿失禁论坛，2020 年，尿失禁影响了 4-8% 的人口，即全球近 4 亿人的生活。 此外，在钬和铥雷射治疗系统中越来越多地采用微创手术是推动泌尿外科雷射市场的主要因素之一。 这些系统具有多项优势，例如更高的效率、安全性和更快的恢復速度，从而增加了对铥和钬系统的需求。

此外，雷射手术具有恢復快、住院时间短、失血少、切口小、全身疼痛小等优点。 因此，预计这些系统的可靠性和安全性将推动市场增长。 此外，所研究市场的主要参与者经常关注产品开发或批准，预计这将在预测期内显着推动市场。 例如，2020 年 6 月，奥林巴斯宣布了 Soltive SuperPulsed 雷射系统（Soltive Laser System），这是一种铥光纤雷射技术的新应用，专为碎石术和软组织应用而设计。 因此，预计这些因素将在预测期内推动市场增长。

泌尿外科雷射市场趋势

良性前列腺增生症 (BPH) 有望成为泌尿外科雷射市场创收最高的应用领域

BPH 是一种涉及前列腺肥大的疾病，在男性中更为常见。 BPH 是由前列腺细胞不受控制的生长引起的非癌性前列腺增生。 与 BPH 相关的常见症状包括尿频、排尿困难、泌尿系统衰弱和无法排空膀胱。

由于BPH患者以老年人居多，随着人口老龄化的加剧，这种疾病的负担也在增加，从而增加了该领域对雷射治疗的需求。 根据世界老龄化人口报告，到 2020 年，全球将有大约 7.27 亿人生活在 65 岁及以上。 未来30年，这一老年人口将稳步增长，翻一番以上，预计到2050年将超过15亿。 预计东亚和东南亚在未来几年内的增长率将超过任何其他地区（约 3.12 亿人）。 此外，全球老年人高风险膀胱癌负担的增加也有望推动市场增长。

此外，根据 2020 年 5 月发表的一项题为“提示老年男性良性前列腺增生的下尿路症状的患病率和相关因素”的研究，该病在老年人（70 岁）中的患病率更高。以上）最高，达到约 22.7%。 此外，正在研究几种新的雷射疗法以改善患者的治疗效果。 例如，2020 年 12 月，澳大利亚圣文森特私立医院的一组外科医生正在研究一种基于虚拟篮子技术在意大利设计的 152 瓦雷射，用于治疗良性前列腺增生症。 预计此类案例将支持市场的增长。

此外，随着 COVID-19 后疫情的逐渐恢復，医疗保健提供者正在将重点转移到 BPH 治疗上，预计将以乐观的态度积极合作治疗 BPH。 . 这将促进所研究的市场。 因此，预计该细分市场在预测期内将实现强劲增长。

预计在预测期内北美将占据重要的市场份额

北美目前在泌尿外科雷射设备市场占据主导地位，并且由于尿石症、BPH 和其他泌尿外科相关疾病的增加，预计在未来几年仍将占据主导地位。 在美国，膀胱癌、尿失禁等泌尿外科疾病日益增多，微创手术因其手术时间短、并发症少而备受青睐，有望成为系统雷射市场中最大的市场。

在美国，新技术的出现和采用正在推动市场的增长。 不断上涨的医疗费用是推动该国医疗保健行业增长的主要因素。 据美国癌症协会估计，2020 年美国将发生 81,400 例膀胱癌新病例（62,100 名男性和 19,300 名女性），约有 17,980 人死于该病。我知道这一点。

根据美国人口普查局 2019 年的估计，2018 年至 2019 年，65 岁及以上人口预计将增长 3.2%，从 2020 年的约 5600 万增加到 2060 年的 9400 万。 老年人往往容易患泌尿系统疾病，尤其是尿失禁，这推动了市场增长。 雷射疗法似乎是治疗女性尿失禁的一种很有前途的替代方法。 该国有一家历史悠久的公司，不断致力于新产品的开发。 2020年10月，奥林巴斯推出了Soltive SuperPulsed雷射系统（Soltive Laser System），专为碎石术和软组织应用而设计的铥光纤雷射技术应用。 因此，上述因素有望促进该地区泌尿外科雷射市场的增长。

其他福利。

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第1章介绍

• 研究假设和市场定义
• 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

• 市场概览
• 市场驱动因素
  • 泌尿系统疾病患病率增加
  • 技术进步
  • 对微创手术的需求不断增长
• 市场製约因素
  • 雷射系统成本高
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

• 按雷射类型
  • 钬雷射系统
  • 二极管雷射系统
  • 铥雷射系统
  • 其他雷射类型
• 通过申请
  • 良性前列腺增生症
  • 尿石症
  • 非肌层浸润□□性膀胱癌
  • 其他用途
• 按地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东
    • 海湾合作委员会
    • 南非
    • 其他中东地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲

第6章竞争格局

• 公司简介
  • Allengers
  • Biolitec AG
  • Boston Scientific Corporation
  • Cook Group
  • El.En. Group
  • Lumenis
  • Medtronic
  • Olympus Corporation
  • OmniGuide Holdings Inc.
  • Richard Wolf GmbH
  • Surgical Lasers Inc.
  • Dornier MedTech

第7章 市场机会与今后动向

The urology laser market was valued at approximately USD 944.79 million in 2020 and is expected to record a CAGR of 5.51% over the forecast period.

The COVID-19 pandemic is expected to significantly impact the market's growth. In addition to the effects of the coronavirus on public health, there has been the collateral effect of near-universal disruption and cancelation of surgical services, which had unprecedented implications for surgical services and patients with surgical conditions. Operating theaters and anesthesia machines are being temporarily converted to respiratory support units in regions with a high disease burden. Additionally, as per the study titled, "Elective Surgery Cancellations due to the COVID-19 Pandemic: Global Predictive Modeling to Inform Surgical Recovery Plans," published in May 2020, approximately 2.5 million urological benign surgeries were reported to have been canceled during the peak disruption of the COVID-19 pandemic. Over the coming weeks, healthcare workers, including urologists, may face increasingly complex challenges. Thus, they should adopt the triage strategy to avoid wasting medical resources. They should also endorse good protection policies to guard against infection when dealing with COVID-19 patients. Owing to the abovementioned factors, the pandemic is likely to have a short-term negative impact on the market studied due to the postponed elective surgeries.

One of the major factors driving the market studied is the high prevalence of urologic conditions worldwide. The prevalence of urinary incontinence is higher in women than in men. According to the Global Forum on Incontinence, 2020, urinary incontinence affects between 4-8% of the population or the lives of almost 400 million people worldwide. Also, the rising adoption of minimally invasive surgical procedures in holmium systems and thulium laser treatment systems is one of the major factors propelling the market for urology lasers. These systems offer several benefits, such as greater efficiency, safety, and rapid recovery, resulting in increased demand for thulium and holmium systems.

Furthermore, laser procedures provide benefits such as faster recovery, shorter hospital stays, decreased blood loss, and lower overall body pain resulting from smaller incisions. Hence, these systems' reliability and safety features are expected to drive market growth. Additionally, key players in the market studied are focusing on frequent product developments and approvals, which is expected to substantially drive the market during the forecast period. For instance, in June 2020, Olympus launched its new Soltive SuperPulsed Laser System (Soltive Laser System), a new application of thulium fiber laser technology designed for stone lithotripsy and soft tissue applications. Thus, such factors are likely to drive the market's growth during the forecast period.

Urology Laser Market Trends

Benign Prostatic Hyperplasia (BPH) Expected to Generate Highest Revenue in the Application Segment of the Urology Laser Market

Benign prostatic hyperplasia is a medical condition involving the enlargement of the prostate gland, and it is highly prevalent in males. It is a non-cancerous growth of the prostate gland originating from the uncontrolled expansion of prostate cells. The common symptoms associated with BPH include frequent urination, urine initiation difficulties, a weak urinary system, and the inability to empty the urinary bladder.

The majority of the benign prostatic hyperplasia patient population is elderly, and as the geriatric population is growing, the burden of this disease is also increasing, boosting the demand for laser treatment in this segment. According to the World Ageing Population report, in 2020, around 727 million people aged 65 years and above were living across the world. Over the next three decades, this older population is expected to increase steadily and more than double, to reach over 1.5 billion by 2050. Eastern and South-eastern Asia are expected to observe the highest increase by about 312 million in the coming years compared to any other region. Moreover, the growing burden of bladder cancer globally, whose risk is higher among the elderly population, is also expected to boost the market growth.

Furthermore, according to the study titled, "The Prevalence and Associated Factors of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Aging Males," published in May 2020, disease prevalence was the highest in elderly patients (aged 70 years and above), amounting to about 22.7%. Several new laser treatments are also being studied to improve patient outcomes. For instance, in December 2020, a group of surgeons from St Vincent's Private Hospital, Australia, were working with a 152-watt laser based on virtual basket technology and designed in Italy to treat benign prostatic hyperplasia. Such instances are expected to support market growth.

Additionally, as the post-COVID-19 pandemic is gradually resuming, healthcare providers are shifting their focus toward BPH treatment, and an optimistic approach toward active collaboration for BPH treatments is expected. This will boost the market studied. Hence, positive growth is expected in this segment over the forecast period.

North America Expected to Hold Significant Market Share in the Forecast Period

North America currently dominates the market for urology laser devices and is expected to continue its stronghold for a few more years owing to the increasing prevalence of urolithiasis, BPH, and other urology-related disorders. The US is expected to be the largest market for urology lasers in the North American region owing to the increasing prevalence of urological disorders, such as bladder cancer and urinary incontinence, and the growing preference for minimally invasive procedures due to less operative time and fewer complications.

The emergence of novel technologies and their adoption is helping the market studied to grow in the US. Rising healthcare expenditure is the primary factor responsible for the growth of the healthcare sector in the country. According to the American Cancer Society, the estimated new cases of bladder cancer in Americans in 2020 were around 81,400 (men: 62,100, women: 19,300) and about 17,980 deaths occurred due to it in the US.

According to the US Census Bureau 2019 estimates, the population aged 65 years and above increased by 3.2% from 2018 to 2019, and it is expected to rise from around 56 million in 2020 to 94 million by 2060. The older population is often susceptible to urological diseases, especially urinary incontinence, which is propelling the market growth. Laser therapy seems to be a promising alternative approach to urinary incontinence in women. The country has well-established companies that are continuously engaged in developing new products. In October 2020, Olympus launched the Soltive SuperPulsed Laser System (Soltive Laser System) for the application of thulium fiber laser technology designed for stone lithotripsy and soft tissue applications. Hence, the aforementioned factors are expected to contribute to the growth of the urology laser market in the region.

Urology Laser Market Competitor Analysis

The urology laser market is moderately competitive and consists of several major players. In terms of market share, a few major players are currently dominating the market. Some of the companies currently dominating the market are Olympus Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Cook Group, Medtronic, Biolitec AG, and Lumenis Ltd. The key players are involved in various strategic alliances such as acquisitions, collaborations, and new product launches to withstand their position in the global market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increase in Prevalence of Urological Disorders
  • 4.2.2 Technological Advancements
  • 4.2.3 Rising Demand for Minimally Invasive Surgical Procedures
• 4.3 Market Restraints
  • 4.3.1 High Cost of Laser Systems
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

• 5.1 By Laser Type
  • 5.1.1 Holmium Laser System
  • 5.1.2 Diode Laser Systems
  • 5.1.3 Thulium Laser System
  • 5.1.4 Other Laser Types
• 5.2 By Application
  • 5.2.1 Benign Prostatic Hyperplasia
  • 5.2.2 Urolithiasis
  • 5.2.3 Non-Muscle-Invasive Bladder Cancer
  • 5.2.4 Other Applications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 US
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 UK
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Allengers
  • 6.1.2 Biolitec AG
  • 6.1.3 Boston Scientific Corporation
  • 6.1.4 Cook Group
  • 6.1.5 El.En. Group
  • 6.1.6 Lumenis
  • 6.1.7 Medtronic
  • 6.1.8 Olympus Corporation
  • 6.1.9 OmniGuide Holdings Inc.
  • 6.1.10 Richard Wolf GmbH
  • 6.1.11 Surgical Lasers Inc.
  • 6.1.12 Dornier MedTech

7 MARKET OPPORTUNITIES AND FUTURE TRENDS